Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · IEX Real-Time Price · USD
400.76
-4.15 (-1.02%)
At close: Apr 24, 2024, 4:00 PM
403.00
+2.24 (0.56%)
After-hours: Apr 24, 2024, 7:57 PM EDT

Vertex Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Net Income
3,6203,3222,3422,7121,1772,097263.48-112.05-556.33-738.56
Upgrade
Depreciation & Amortization
181.3148.3125.6109.5106.972.4261.461.462.3463.26
Upgrade
Share-Based Compensation
581.2491.3441.4429.5360.5325.05293.24240.62231.03175.38
Upgrade
Other Operating Activities
-844.8168.3-265.62.8-74.9-1,224.08226.8346.13-102.47-73.2
Upgrade
Operating Cash Flow
3,5374,1302,6443,2541,5691,270844.94236.1-365.43-573.11
Upgrade
Operating Cash Flow Growth
-14.35%56.23%-18.75%107.32%23.54%50.34%257.87%---
Upgrade
Capital Expenditures
-200.4-204.7-235-259.8-75.4-95.45-99.42-56.56-45.3-51.2
Upgrade
Acquisitions
0-295.900-1,154.2-7.9-61.60-80-10
Upgrade
Change in Investments
-2,883.3179.5-105.9359.2-5.7-98.81-163.37107.86416.09143.45
Upgrade
Other Investing Activities
-58------158.94-0.06-21.93-0.24
Upgrade
Investing Cash Flow
-3,141.7-321.1-340.999.4-1,235.3-202.16-483.3351.24268.8682.01
Upgrade
Share Issuance / Repurchase
-519.114.3-1,459.3-474.5151.2-60.75344.8468.23185.59274.62
Upgrade
Debt Issued / Paid
-43.1-82-18.7-29-29.2-12.55-288.94-9.963.33272.46
Upgrade
Other Financing Activities
----1.84.82.0812.575-2.16
Upgrade
Financing Cash Flow
-562.2-67.7-1,478-505.3126.8-71.2268.4133.27188.92549.24
Upgrade
Exchange Rate Effect
26.9-29.2-13.420.61.6-6.185.8-4.67-2.83-2.18
Upgrade
Net Cash Flow
-139.73,712811.22,868462.4990.73435.82415.9589.5155.96
Upgrade
Free Cash Flow
3,3373,9252,4092,9941,4941,175745.52179.54-410.73-624.31
Upgrade
Free Cash Flow Growth
-14.99%62.97%-19.55%100.39%27.16%57.59%315.24%---
Upgrade
Free Cash Flow Margin
33.81%43.95%31.80%48.24%35.89%38.55%29.96%10.55%-39.79%-107.56%
Upgrade
Free Cash Flow Per Share
12.9515.339.3511.525.824.623.000.73-1.70-2.65
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).